Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
10/2008
10/22/2008CN100427486C Novel benzimidazole derivatives
10/21/2008US7439374 e.g. 4-[3-(Furo[3,2-c]pyridin-2-yl-carbonyl)-thioureido]-benzoic acid butyl ester; viricide; hepatitis C (HCV) infections, cirrhosis, end-stage liver disease, and liver cancer; side effects reducer
10/21/2008US7439364 Process for the synthesis of derivatives of halo-[2,3-F] quinoline
10/21/2008US7439354 Process for preparing amide acetals
10/21/2008US7439251 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
10/21/2008US7439247 Bicyclic pyridine and pyrimidine P38 kinase inhibitors
10/21/2008CA2296012C Epothilone derivatives
10/16/2008US20080255347 Process for making galantamine
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255175 4-Ethyl-4-(1,4-dioxo-3-azahept-5-enoxy-),9-desamino-camptothecin where the 9-amino may be present as dimethylamino with an alkyl sulfo group on carbon #8; Camptothecin derivatives having greater biological activity/enhanced stability, topoisomerase I inhibitors; side effect reductions; antitumor agents
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080255118 Cyanopyrimidinones
10/16/2008US20080255059 Regulators of the hedgehog pathway, compositions and uses related thereto
10/16/2008US20080251754 Ionic onium compound with imidide; high ionic conductivity, delocalized anionic charge
10/15/2008EP1979318A1 Amido compounds and their use as pharmaceuticals
10/15/2008EP1979308A1 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
10/15/2008EP1692124B1 Biaryl sulfonamides as mmp inhibitors
10/15/2008EP1603901B1 Tetrahydropyran compounds as tachykinin antagonists
10/15/2008EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/15/2008EP0363415B1 Compounds for the treatment of alzheimer's disease
10/15/2008CN101287737A Pentacyclic kinase inhibitors
10/15/2008CN101287719A Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
10/15/2008CN101284832A Preparation method of (4S, 5R)- half-ester
10/15/2008CN100425611C Process for making camptothecin derivatives
10/14/2008US7435829 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
10/14/2008US7435821 Reacting a 3-leaving group-1-(p-leaving group-phenyl)tetrahydro-2-pyridone with 2-hydroxypyridine and reacting the product with an alpha-oxoacetaldehyde phenylhydrazone to form 1-phenyl-3-carbonyl-6-(p-(2-pyridon-1-yl)phenyl-4,5-dihydro-pyrazolo[3,4-c]pyrid-2-one derivatives; bases; aprotic solvents
10/14/2008US7435820 Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and use
10/14/2008US7435818 Crystal forms of irinotecan hydrochloride
10/14/2008US7435817 C-14 oxidation of morphine derivatives
10/14/2008US7435816 A benzylidenegalactose-solasodine conjugate intermediate its preparation and its use in preparing solasonine
10/14/2008US7435745 Methods and compositions for inhibition of angiogenesis
10/14/2008US7435740 e.g. 1-Benzyl-7-phenyl-3-propyl-1H-pyrrolo[1,2-f]purine-2,4(3H,6H)-dione; antiinflammatory, anticarcinogenic agent; cerebral ischemia, asthma, neurodegeneration, glaucoma, ischemic heart pre-conditioning; diagnostic agents
10/14/2008CA2275351C Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
10/09/2008WO2008121066A1 Novel tricyclic spiropiperidines or spiropyrrolidines and their use as modulators of chemokine receptors
10/09/2008WO2008120761A1 Heteroaryl derivative
10/09/2008WO2008119797A1 Dinaphthoquaterrylene as a photosensitizer in solar cells
10/09/2008WO2008119744A1 Heterocyclic spiro-compounds
10/09/2008US20080249085 for treating cell proliferative diseases; maytansinoid analogs; with lower systemic toxicity, improved pharmacokinetic profile, and better clinical activity; inhibiting fungal growth; compounds can target tubulin, Heat Shock Protein-90
10/09/2008US20080249084 For diabetes, obesity or metabolic syndrome; improve physicochemical (like stability) and biological (inhibitor activity, specificity, bioavailability, metabolism) profiles; 11Beta-hydroxysteroid dehydrogenase 1 inhibitors; 3-chloro-4-[4-methyl-5-(1-phenyl-cyclopropyl)-4H-[1,2,4]triazol-3-yl]-benzamide
10/09/2008CA2682377A1 Heteroaryl derivatives
10/09/2008CA2681978A1 Heterocyclic spiro-compounds
10/08/2008EP1976854A2 Heterocycles as nicotinic acid receptor agonists for the treatment of dyyslipidemia
10/08/2008EP1976849A2 Compounds for the treatment of inflammatory disorders
10/08/2008EP1606283B1 P38 inhibitors and methods of use thereof
10/08/2008EP1485390B1 Bicyclic pyridine and pyrimidine p38 kinase inhibitors
10/08/2008EP1283042B1 Aqueous liquid preparation of pranoprofen
10/08/2008CN100424085C Total alkaloid of xiatianwu (a Chinese medicinal material), its preparation method and application
10/07/2008US7432375 JNK inhibitors
10/07/2008US7432283 Heterocyclic GABAA subtype selective receptor modulators
10/07/2008US7432278 Dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents
10/07/2008US7432277 Phosphorus-containing macrocycles
10/07/2008US7432276 amino(4-methoxy-7,7-dimethyl(7,12,12a,6a-tetrahydrochromano[4,3-b]quinolin-9-yl))methane-1-thione; increasing cellular ATP binding cassette transporter ABCA1 production ; reduces cholesterol deposition in coronary arteries; coronary artery diseases, dyslipidiemias and metabolic syndrome
10/07/2008US7432275 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators
10/07/2008US7432267 imidazo(1,5-a)-pyrazine-1,3-dione derivatives; Anticancer agents; immune disorders; (5S,8S,8aR)-4-[Octahydro-7-[(1,1-dimethylethoxy)carbonyl]-1,3-dioxo-5,8-methanoimidazo[1,5-a]pyrazin-2-yl]-2-(trifluoromethyl)benzonitrile
10/07/2008US7432088 Using actinomycetes to ferment maytansines
10/07/2008CA2335300C Macrocyclic analogs and methods and their use and preparation
10/07/2008CA2248143C Process to prepare oxazolidinones
10/02/2008WO2008092877A3 8-oxa-1, 4-diazaspiro [4,5] dec-3-en-1-yl and 1,4, 8-triazaspiro [4,5] dec- 3-en-1-yl acetamides as glyti transporter inhibitors in treatment of neurological and neuropsychiatric disorders
10/02/2008WO2007117591A9 Total synthesis of salinosporamide a and analogs thereof
10/02/2008US20080242692 Synthesis of Indenoisoquinoliniums and Methods of Use
10/01/2008EP1973909A2 Transforming growth factor modulators
10/01/2008EP1973900A1 Hydantoin compounds for the treatment of inflammatory disorders
10/01/2008EP1973898A1 Pdf inhibitors
10/01/2008EP1973878A1 Process and intermediate for preparation of donepezil
10/01/2008EP1732922B1 Methods for minimizing thioamide impurities
10/01/2008EP1399424B8 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide
10/01/2008CN101277955A Cyclic amine compound and pest control agent
10/01/2008CN101274929A Thrombin receptor antagonists
10/01/2008CN100422310C Agricultural antibiotic strain for producing fungus killer and its preparing process
10/01/2008CN100422188C Method for separating preparing tripterygium wilfordii monomer from tripterygium wilfordii by countercurrent flow chromatography
10/01/2008CN100422187C New method for extracting cephalotaxine and percephalotaxine
10/01/2008CN100422173C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
10/01/2008CN100422172C Substituted pyridines and pyridazines with angiogenesis inhibiting activity
09/2008
09/30/2008US7429660 Induce immunology response; anticancer agents
09/30/2008US7429603 C-fms kinase inhibitors
09/30/2008US7429600 Fluorenecarboxylic acid esters, process for the manufacture thereof, and use thereof as medicaments
09/30/2008US7429599 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
09/30/2008US7429586 Non-imidazole aryloxyalkylamines
09/30/2008US7429584 Furo[2.3-b]pyridine derivatives for the treatment of hyper-proliferative disorders
09/30/2008CA2417417C Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
09/25/2008WO2008115990A1 Methods of preparation and resolution of e/z isomers of vinylfuro[2,3-d] pyrimidine and their biological activities and related compositions and methods of treatment
09/25/2008WO2008115820A1 Combination of a narcotic and a non-narcotic analgesic
09/25/2008WO2008114123A1 Spiro benzimidazole derivatives as acid pump inhibitors
09/25/2008WO2008114054A1 Protease inhibitors
09/25/2008WO2008113456A1 Tetrahydroquinoline derivatives and use of same for treating cancer
09/25/2008WO2008113451A1 Substituted tetrahydroquinolines
09/25/2008WO2008094574A3 Furanone compounds and methods of making and using the same
09/25/2008WO2008077810A3 Spiro-piperidine derivatives
09/25/2008WO2005066180A9 Cysteine protease inhibitors
09/25/2008US20080234309 Macrocyclic lactone compounds and methods for their use
09/25/2008US20080234260 Cysteine Protease inhibitors
09/25/2008US20080234256 Antibacterial Agents
09/25/2008US20080234247 Heterocyclic analgesic compounds and methods of use thereof
09/25/2008US20080233609 Spirolactam Targeting Compounds and Related Compounds
09/25/2008DE102007013855A1 Substituierte Tetrahydrochinoline Substituted tetrahydroquinolines
09/25/2008DE102007013854A1 Tetrahydrochinoline Tetrahydroquinolines
09/25/2008CA2681261A1 Tetrahydroquinoline derivatives and the use thereof for the treatment of cancer
09/25/2008CA2681256A1 Substituted pyranyl quinolines
09/24/2008EP1972632A1 Oxabicycloalkanones as fragrances
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 298